Fusion Pharmaceuticals | IPO Presentation Deck

Slide schematic 5/5

callout 1/1 image 1/1 table 1/1 title 2/2

Components 5

primary illustration data action-title headline

Tools 1

Ovarian 100%, Bladder 100%, Sarcomas 90%, Head and Neck 62%, Prostate 62%, NSCLC 59%, Pancreatic 57%, Colorectal 50%, Liver 50%, Breast 47%, Small Cell Lung 43%, Esophagus 40%, Renal 36%, ACC 36%

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 1

evidence-matrix 80%

Presents a list of tumor types and their corresponding expression percentages to justify clinical utility.

Find anything

The slide uses a human body diagram to visually represent the systemic nature of the target.